Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
19997 | 481 | 46.2 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
12 | 4 | POLYMER SCIENCE//MATERIALS SCIENCE, PAPER & WOOD//CHEMISTRY, PHYSICAL | 1084170 |
41 | 3 | INTERNATIONAL JOURNAL OF PHARMACEUTICS//DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY//PHARMACOLOGY & PHARMACY | 99449 |
147 | 2 | SOLID LIPID NANOPARTICLES//POLYMERIC MICELLES//LIPOSOMES | 23275 |
19997 | 1 | HYALURONIC ACID//HYALURONIC ACID CERAMIDE//GLYCYRRHETINIC ACID | 481 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HYALURONIC ACID | authKW | 400371 | 31% | 4% | 150 |
2 | HYALURONIC ACID CERAMIDE | authKW | 380892 | 1% | 100% | 6 |
3 | GLYCYRRHETINIC ACID | authKW | 264195 | 7% | 13% | 32 |
4 | ZHEJIANG HUAFON FIBER | address | 253928 | 1% | 100% | 4 |
5 | CD44 RECEPTOR | authKW | 253916 | 2% | 40% | 10 |
6 | FLT1 PEPTIDE | authKW | 190446 | 1% | 100% | 3 |
7 | BIOADHESIVE LIPOSOMES | authKW | 142833 | 1% | 75% | 3 |
8 | GEORG S WISE LIFE SCI | address | 142833 | 1% | 75% | 3 |
9 | ANTI FLT1 PEPTIDE | authKW | 126964 | 0% | 100% | 2 |
10 | ARACHIDYL CHITOSAN | authKW | 126964 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Materials Science, Biomaterials | 5566 | 18% | 0% | 86 |
2 | Pharmacology & Pharmacy | 1216 | 31% | 0% | 147 |
3 | Engineering, Biomedical | 1000 | 12% | 0% | 57 |
4 | Nanoscience & Nanotechnology | 737 | 14% | 0% | 67 |
5 | Chemistry, Multidisciplinary | 691 | 26% | 0% | 126 |
6 | Polymer Science | 339 | 11% | 0% | 53 |
7 | Chemistry, Organic | 107 | 8% | 0% | 40 |
8 | Chemistry, Applied | 98 | 5% | 0% | 24 |
9 | Medicine, Research & Experimental | 68 | 6% | 0% | 27 |
10 | Chemistry, Medicinal | 63 | 4% | 0% | 20 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ZHEJIANG HUAFON FIBER | 253928 | 1% | 100% | 4 |
2 | GEORG S WISE LIFE SCI | 142833 | 1% | 75% | 3 |
3 | BIOENGN NANOMED GRP | 126964 | 0% | 100% | 2 |
4 | DIPARTEMENTO SCI TECNOL FARM | 126964 | 0% | 100% | 2 |
5 | DRUG DELIVERY FORMULAT GRP | 114265 | 1% | 60% | 3 |
6 | UNIT BIOMOL DETERMINANTS PROGNOSIS THER Y | 81616 | 1% | 43% | 3 |
7 | BIOMED REASEARCH | 63482 | 0% | 100% | 1 |
8 | CABIMERUPO | 63482 | 0% | 100% | 1 |
9 | CELL SCREENING IL PERSONALIZED MED | 63482 | 0% | 100% | 1 |
10 | CELL SCREENING IL PERSONALIZED MEDSAGOL N | 63482 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CONTROLLED RELEASE | 6671 | 6% | 0% | 28 |
2 | BIOMATERIALS | 6429 | 8% | 0% | 39 |
3 | MOLECULAR PHARMACEUTICS | 3933 | 3% | 0% | 14 |
4 | INTERNATIONAL JOURNAL OF NANOMEDICINE | 3330 | 3% | 0% | 13 |
5 | NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE | 2414 | 1% | 1% | 7 |
6 | ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY | 2108 | 1% | 1% | 4 |
7 | JOURNAL OF DRUG TARGETING | 1989 | 1% | 0% | 7 |
8 | BIOCONJUGATE CHEMISTRY | 1525 | 2% | 0% | 11 |
9 | PHARMACEUTICAL RESEARCH | 1323 | 3% | 0% | 13 |
10 | NANOMEDICINE | 1294 | 1% | 0% | 5 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HYALURONIC ACID | 400371 | 31% | 4% | 150 | Search HYALURONIC+ACID | Search HYALURONIC+ACID |
2 | HYALURONIC ACID CERAMIDE | 380892 | 1% | 100% | 6 | Search HYALURONIC+ACID+CERAMIDE | Search HYALURONIC+ACID+CERAMIDE |
3 | GLYCYRRHETINIC ACID | 264195 | 7% | 13% | 32 | Search GLYCYRRHETINIC+ACID | Search GLYCYRRHETINIC+ACID |
4 | CD44 RECEPTOR | 253916 | 2% | 40% | 10 | Search CD44+RECEPTOR | Search CD44+RECEPTOR |
5 | FLT1 PEPTIDE | 190446 | 1% | 100% | 3 | Search FLT1+PEPTIDE | Search FLT1+PEPTIDE |
6 | BIOADHESIVE LIPOSOMES | 142833 | 1% | 75% | 3 | Search BIOADHESIVE+LIPOSOMES | Search BIOADHESIVE+LIPOSOMES |
7 | ANTI FLT1 PEPTIDE | 126964 | 0% | 100% | 2 | Search ANTI+FLT1+PEPTIDE | Search ANTI+FLT1+PEPTIDE |
8 | ARACHIDYL CHITOSAN | 126964 | 0% | 100% | 2 | Search ARACHIDYL+CHITOSAN | Search ARACHIDYL+CHITOSAN |
9 | CD44 TARGETED DELIVERY | 126964 | 0% | 100% | 2 | Search CD44+TARGETED+DELIVERY | Search CD44+TARGETED+DELIVERY |
10 | DOUBLE PH SENSITIVE | 126964 | 0% | 100% | 2 | Search DOUBLE+PH+SENSITIVE | Search DOUBLE+PH+SENSITIVE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | DOSIO, F , ARPICCO, S , STELLA, B , FATTAL, E , (2016) HYALURONIC ACID FOR ANTICANCER DRUG AND NUCLEIC ACID DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 97. ISSUE . P. 204 -236 | 107 | 38% | 18 |
2 | ARPICCO, S , MILLA, P , STELLA, B , DOSIO, F , (2014) HYALURONIC ACID CONJUGATES AS VECTORS FOR THE ACTIVE TARGETING OF DRUGS, GENES AND NANOCOMPOSITES IN CANCER TREATMENT.MOLECULES. VOL. 19. ISSUE 3. P. 3193 -3230 | 66 | 51% | 24 |
3 | CADETE, A , ALONSO, MJ , (2016) TARGETING CANCER WITH HYALURONIC ACID-BASED NANOCARRIERS: RECENT ADVANCES AND TRANSLATIONAL PERSPECTIVES.NANOMEDICINE. VOL. 11. ISSUE 17. P. 2341 -2357 | 47 | 43% | 0 |
4 | RAO, NV , YOON, HY , HAN, HS , KO, H , SON, S , LEE, M , LEE, H , JO, DG , KANG, YM , PARK, JH , (2016) RECENT DEVELOPMENTS IN HYALURONIC ACID-BASED NANOMEDICINE FOR TARGETED CANCER TREATMENT.EXPERT OPINION ON DRUG DELIVERY. VOL. 13. ISSUE 2. P. 239 -252 | 34 | 36% | 8 |
5 | TRIPODO, G , TRAPANI, A , TORRE, ML , GIAMMONA, G , TRAPANI, G , MANDRACCHIA, D , (2015) HYALURONIC ACID AND ITS DERIVATIVES IN DRUG DELIVERY AND IMAGING: RECENT ADVANCES AND CHALLENGES.EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. VOL. 97. ISSUE . P. 400 -416 | 36 | 32% | 10 |
6 | SARAVANAKUMAR, G , DEEPAGAN, VG , JAYAKUMAR, R , PARK, JH , (2014) HYALURONIC ACID-BASED CONJUGATES FOR TUMOR-TARGETED DRUG DELIVERY AND IMAGING.JOURNAL OF BIOMEDICAL NANOTECHNOLOGY. VOL. 10. ISSUE 1. P. 17-31 | 28 | 40% | 9 |
7 | NIKITOVIC, D , KOUVIDI, K , KAVASI, RM , BERDIAKI, A , TZANAKAKIS, GN , (2016) HYALURONAN/HYALADHERINS - A PROMISING AXIS FOR TARGETED DRUG DELIVERY IN CANCER.CURRENT DRUG DELIVERY. VOL. 13. ISSUE 4. P. 500 -511 | 42 | 26% | 1 |
8 | OYARZUN-AMPUERO, FA , RIVERA-RODRIGUEZ, GR , ALONSO, MJ , TORRES, D , (2013) HYALURONAN NANOCAPSULES AS A NEW VEHICLE FOR INTRACELLULAR DRUG DELIVERY.EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 49. ISSUE 4. P. 483-490 | 22 | 50% | 13 |
9 | GHOSH, SC , ALPAY, SN , KLOSTERGAARD, J , (2012) CD44: A VALIDATED TARGET FOR IMPROVED DELIVERY OF CANCER THERAPEUTICS.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 16. ISSUE 7. P. 635 -650 | 31 | 31% | 54 |
10 | ZHENG, WY , LI, YQ , DU, JP , YIN, ZN , (2014) FABRICATION OF BIOCOMPATIBLE AND TUMOR-TARGETING HYALURONAN NANOSPHERES BY A MODIFIED DESOLVATION METHOD.JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 103. ISSUE 5. P. 1529 -1537 | 19 | 48% | 3 |
Classes with closest relation at Level 1 |